CVR: 36900709
Secondary names: Salient Medical ApS, Zerotaste ApS
Salient Pharma ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Ulrik Spork. The company is owned by HB-MEDICAL HOLDING ApS, CAND.PHARM. POVL M. ASSENS FOND and SPORCON LIFESCIENCE ADVISORS ApS. In 2025, the company reported a gross profit of DKK -129,889 and a net result of DKK -218,345 compared with DKK -202,180 the year before. Equity amounted to DKK -1,344,010.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udøve virksomhed med udvikling, fremstilling samt markedsføring af produkter inden for life-science området samt dertil knyttede aktiviteter
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -130 t. | -218 t. | 45 t. | -1.3 mio. | 0 | |
| 2024 | -124 t. | -202 t. | 19 t. | -1.1 mio. | 0 | |
| 2023 | -233 t. | -305 t. | 21 t. | -1.2 mio. | 0 | |
| 2022 | -126 t. | -188 t. | 58 t. | -981 t. | 0 | |
| 2021 | -259 t. | -301 t. | 55 t. | -793 t. | 0 | |
| 2020 | -485 t. | -902 t. | 45 t. | -492 t. | 1 | |
| 2019 | -730 t. | -2.4 mio. | 579 t. | 410 t. | 1 | |
| 2018 | -838 t. | -710 t. | 2.9 mio. | 2.8 mio. | - | |
| 2017 | -1.2 mio. | -971 t. | 399 t. | -1.8 mio. | - | |
| 2016 | -955 t. | -772 t. | 592 t. | -847 t. | - |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Salient Pharma ApS has published its annual report for 2025. Gross profit came to DKK -129,889, and the net result was DKK -218,345.
As of August 26, 2025, Søren Johannes Kjær Henningsen has left the board of directors of Salient Pharma ApS.
Salient Pharma ApS has published its annual report for 2024. Gross profit came to DKK -124,372, and the net result was DKK -202,180.
Salient Pharma ApS has published its annual report for 2023. Gross profit came to DKK -233,306, and the net result was DKK -304,925.
As of December 31, 2023, HB-MEDICAL HOLDING ApS is registered as an owner of Salient Pharma ApS with an ownership share of 33%.
As of December 31, 2023, CAND.PHARM. POVL M. ASSENS FOND is registered as an owner of Salient Pharma ApS with an ownership share of 15%.
As of December 31, 2023, SPORCON LIFESCIENCE ADVISORS ApS is registered as an owner of Salient Pharma ApS with an ownership share of 25%.
Salient Pharma ApS has published its annual report for 2022. Gross profit came to DKK -125,514, and the net result was DKK -188,162.
As of July 7, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Salient Pharma ApS.
Salient Pharma ApS has published its annual report for 2021. Gross profit came to DKK -259,487, and the net result was DKK -301,256.
Salient Pharma ApS has published its annual report for 2020. Gross profit came to DKK -484,922, and the net result was DKK -901,594.
Salient Pharma ApS has published its annual report for 2019. Gross profit came to DKK -729,822, and the net result was DKK -2,359,834.
Salient Pharma ApS has published its annual report for 2018. Gross profit came to DKK -837,788, and the net result was DKK -710,176.
As of August 31, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Salient Pharma ApS.
As of August 31, 2018, Søren Wang Petersen has joined the board of directors of Salient Pharma ApS.
As of August 31, 2018, Helle Bøwadt has joined the board of directors of Salient Pharma ApS.
As of August 31, 2018, Søren Johannes Kjær Henningsen has joined the board of directors of Salient Pharma ApS.
Salient Pharma ApS has published its annual report for 2017. Gross profit came to DKK -1,244,332, and the net result was DKK -970,745.
Salient Pharma ApS has published its annual report for 2016. Gross profit came to DKK -954,993, and the net result was DKK -772,477.
Salient Pharma ApS has published its interim report for the period May 21, 2015 – December 31, 2015.
As of May 21, 2015, Ulrik Spork has joined the board of directors of Salient Pharma ApS.
As of May 21, 2015, Ulrik Spork is registered as director of Salient Pharma ApS.
Salient Pharma ApS was founded on May 21, 2015.
Companies in the same industry and area
CVR 26385180
CVR 26543673
CVR 32049478
CVR 39720213
CVR 83744014
companydata.dk